Mutation Research/DNA Repair
Mini reviewRepair of DNA interstrand cross-links
Introduction
DNA interstrand cross-links (ICLs) are among the most toxic DNA damages. A single ICL can kill repair-deficient bacteria and yeast, and about 40 ICLs can kill repair-deficient mammalian cells [1], [2]. Moreover, ICLs can induce mutations and rearrangements of DNA, possibly resulting in uncontrolled cell growth and tumor formation. Many different agents are capable of inducing ICLs into the genome. A well-known class of ICL-inducers are chemotherapeutic agents like mitomycin C, cisplatin, nitrogen mustard, nitrosourea, and their derivatives. However, cells are also exposed to environmental ICL agents, like furocoumarins that are present in many plants and cosmetics [3]. Moreover, endogenous agents that are formed during lipid peroxidation, such as malondialdehyde, can lead to ICLs. However, the clinical relevance of these endogenous agents is unclear, because they are unstable and hardly form ICLs under physiological conditions [4], [5]. Organisms have developed strategies to deal with DNA damage in order to survive. A number of specialized repair pathways have evolved that each process specific kinds of DNA damage. An intriguing aspect of ICL repair is that several of these pathways have to work together in order to remove or bypass an ICL. While the major ICL repair pathway in bacteria is well-characterized, both genetically and biochemically, ICL repair in eukaryotes is less well understood.
First, we will discuss a number of important properties of ICL agents and the DNA damage with which they confront the cells. Next, the clinical relevance of knowledge concerning ICL repair for the treatment of cancer will be surveyed, followed by a review of the current insights in the mechanisms of ICL repair in bacteria, yeast and mammalian cells.
Section snippets
Cross-link formation and properties of DNA interstrand cross-linking agents
ICL agents have different toxicities depending on a number of factors, including cellular uptake and metabolic activation. First, most ICL agents have to be transported into the cell and then into the nucleus. Second, a number of ICL agents, such as the nitrosoureas, are metabolically activated in the cell, yielding an agent with a much higher activity [6]. Metabolism also yields other damaging agents. Mitomycin C, for example, undergoes a cycle of oxidation and reduction, thereby activating
Clinical relevance of DNA interstrand cross-links
As mentioned above, many ICL-inducing agents are used in the treatment of cancer. Knowledge about the formation and repair of these ICLs enables us to understand the clinical effectiveness and side-effects of these agents and to improve cytostatic therapy. Knowledge about ICL repair is also relevant for Fanconi anemia patients, whose cells are specifically sensitive to ICL agents. Fanconi anemia will be discussed later.
Cytostatic therapy is based on selective killing of tumor cells, while
Detection of DNA interstrand cross-links and repair intermediates
It is important to be aware of the methods used to assess the level of ICLs and their repair intermediates to correctly interpret the data that are obtained. It has to be kept in mind that ICLs form only a small fraction of the induced DNA damage, except when one ICL has been produced at a specific position on a plasmid. The damage response, repair activity and survival of the cell are also determined by the other types of damage. The main difference between an ICL and any other DNA damage is
DNA interstrand cross-link repair in Escherichia coli
ICL repair in E. coli has been characterized both genetically and biochemically. In the major pathway of ICL repair, nucleotide excision repair (NER) and homologous recombination work together to remove the ICL [21], [49]. The biochemical work has mainly made use of psoralen ICLs and resulted in a model for ICL repair that is schematically presented in Fig. 1A. In vitro, repair starts with incisions around the ICL in one DNA strand (Fig. 1A2). When a psoralen ICL is present, this is usually the
DNA interstrand cross-link repair in Saccharomyces cerevisiae
ICL repair in S. cerevisiae has not been characterized in as much detail as repair in E. coli. A significant amount of information is available about the genes involved in ICL repair, but not specifically about their involvement in ICL repair (Table 2). Most of these genes belong to one of the DNA repair pathways that process other types of lesions as well: NER, homologous recombination and post-replication/translesion repair [17]. Survival after treatment with ICL agents is also affected by
Finding genes involved in mammalian DNA interstrand cross-link repair
Knowledge about ICL repair in mammalian cells is mainly derived from two sources. The first of these is the knowledge of yeast ICL repair. DNA repair pathways have been conserved in eukaryotes from S. cerevisiae to human (Table 2). Similar to the situation in S. cerevisiae, genes required for NER, homologous recombination, and post-replication/translesion repair are involved in mammalian ICL repair. A number of genes involved in mammalian ICL repair, including RAD6, RAD18, RAD54, SNM1, REV3 and
Acknowledgements
Research on ICL repair in our laboratory is supported by a grant from The Netherlands Organization for Scientific Research (NWO). We thank Y.M. Yamashita and S. Takeda for communicating unpublished results.
References (274)
- et al.
DNA adducts from chemotherapeutic agents
Mutat. Res.
(1996) - et al.
Molecular and genetic basis of furocoumarin reactions
Mutat. Res.
(1976) - et al.
Dissociation of malondialdehyde mutagenicity in Salmonella typhimurium from its ability to induce interstrand DNA cross-links
Mutat. Res.
(1984) - et al.
Genotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)
Mutat. Res.
(1995) Mitomycin C: small, fast and deadly (but very selective)
Chem. Biol.
(1995)- et al.
Is Fanconi anemia caused by a defect in the processing of DNA damage?
Mutat. Res.
(1998) H2O2 generation during the redox cycle of mitomycin C and DNA-bound mitomycin C
Chem. Biol. Interact.
(1976)Cellular responses to cisplatin: the roles of DNA-binding proteins and DNA repair
J. Biol. Chem.
(1994)- et al.
Gene-specific DNA repair of interstrand cross-links induced by chemotherapeutic agents can be preferential
J. Biol. Chem.
(1993) - et al.
Relationships between functionality and genetic toxicology of selected DNA-damaging agents
Mutat. Res.
(1984)
Asymmetric recognition of psoralen interstrand cross-links by the nucleotide excision repair and the error-prone repair pathways
J. Mol. Biol.
Interstrand cross-links of cisplatin induce striking distortions in DNA
J. Inorg. Biochem.
DNA damage and mutagenesis induced by nitrogen mustards
Mutat. Res.
Role of PSO genes in the repair of photo-induced interstrand cross-links and photooxidative damage in the DNA of the yeast Saccharomyces cerevisiae
J. Photochem. Photobiol. B
Formation and disappearance of DNA interstrand cross-links in human colon tumor cell lines with different levels of resistance to chlorozotocin
Biochem. Pharmacol.
Role of platinum–DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines
Biochem. Pharmacol.
Resistance mechanisms associated with altered intracellular distribution of anticancer agents
Pharmacol. Ther.
Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol
Ann. Oncol.
Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for cross-linking agent resistance
Mutat. Res.
In vitro repair of psoralen–DNA cross-links by RecA, UvrABC, and the 5′-exonuclease of DNA polymerase I
J. Biol. Chem.
Removal of psoralen interstrand cross-links from DNA of Escherichia coli: mechanism and genetic control
J. Mol. Biol.
Multiple pathways of recombination define cellular responses to cisplatin
Chem. Biol.
DNA damage by 8-methoxypsoralen plus near ultraviolet light (PUVA) and its repair in Escherichia coli: genetic analysis
Mutat. Res.
Recombinational DNA repair: the RecF and RecR proteins limit the extension of RecA filaments beyond single-strand DNA gaps
Cell
Protein interactions in genetic recombination in Escherichia coli: interactions involving RecO and RecR overcome the inhibition of RecA by single-stranded DNA-binding protein
J. Biol. Chem.
The translocating RecBCD enzyme stimulates recombination by directing RecA protein onto ssDNA in a chi-regulated manner
Cell
Initiation of genetic recombination and recombination-dependent replication
Trends Biochem. Sci.
Cis and trans mechanisms of DNA repair
Curr. Opin. Cell Biol.
Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes
Curr. Biol.
PSO4: a novel gene involved in error-prone repair in Saccharomyces cerevisiae
Mutat. Res.
A yeast mutant specifically sensitive to bifunctional alkylation
Mutat. Res.
Sensing and responding to DNA damage
Curr. Opin. Genet. Dev.
DNA damage and checkpoint pathways: molecular anatomy and interactions with repair
Cell
DNA damage checkpoints and DNA replication controls in Saccharomyces cerevisiae
Mutat. Res.
Preferential incision of interstrand cross-links induced by 8-methoxypsoralen plus UVA in yeast during the cell cycle
Mutat. Res.
Saccharomyces cerevisiae lacking snm1, rev3 or rad51 have a normal S phase but arrest permanently in G2 after cisplatin treatment
Mutat. Res.
Cisplatin–DNA cross-links do not inhibit S phase and cause only a G2/M arrest in Saccharomyces cerevisiae
Mutat. Res.
Pulsed-field gel electrophoresis analysis of the repair of psoralen plus UVA-induced DNA photoadducts in Saccharomyces cerevisiae
Mutat. Res.
Molecular mechanisms of DNA double-strand break repair
Trends Cell Biol.
New aspects of the repair and genotoxicity of psoralen photoinduced lesions in DNA
J. Photochem. Photobiol. B
Genetic control of the bypass of mono-adducts and of the repair of cross-links photoinduced by 8-methoxypsoralen in yeast
Mutat. Res.
Repair of exogenous (plasmid) DNA damaged by photoaddition of 8-methoxypsoralen in the yeast Saccharomyces cerevisiae
Mutat. Res.
Yeast DNA repair protein RAD5 that promotes instability of simple repetitive sequences is a DNA-dependent ATPase
J. Biol. Chem.
Yeast DNA repair proteins Rad6 and Rad18 form a heterodimer that has ubiquitin conjugating, DNA binding, and ATP hydrolytic activities
J. Biol. Chem.
The fate of 8-methoxypsoralen photo-induced cross-links in nuclear and mitochondrial yeast DNA: comparison of wild-type and repair-deficient strains
Proc. Natl. Acad. Sci. U.S.A.
Detection of endogenous malondialdehyde–deoxyguanosine adducts in human liver
Science
Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics
Cancer Res.
Repair of 4,5′,8-trimethylpsoralen plus light-induced DNA damage in normal and Fanconi’s anemia cell lines
Cancer Res.
Molecular genetics and Fanconi anaemia: new insights into old problems
Br. J. Haematol.
Differential introduction of DNA damage and repair in mammalian genes transcribed by RNA polymerases I and II
Mol. Cell Biol.
Cited by (498)
RecN spatially and temporally controls RecA-mediated repair of DNA double-strand breaks
2023, Journal of Biological ChemistryProgress towards a standardized model of ocular sulfur mustard injury for therapeutic testing
2023, Experimental Eye ResearchDNA interstrand crosslink repair by XPF-ERCC1 homologue confers ultraviolet resistance in Neurospora crassa
2023, Fungal Genetics and BiologyRapid DNA interstrand cross-linking of Pt(IV) compound
2022, European Journal of PharmacologyThe ubiquitination machinery of the Fanconi Anemia DNA repair pathway
2021, Progress in Biophysics and Molecular Biology